Albireo Pharma Buy Hold or Sell Recommendation

ALBODelisted Stock  USD 44.15  0.75  1.67%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Albireo Pharma is 'Not Rated'. Macroaxis provides Albireo Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ALBO positions. The advice algorithm takes into account all of Albireo Pharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Albireo Pharma's buy or sell advice are summarized below:
Real Value
32.14
Hype Value
44.15
Market Value
44.15
Naive Value
48.86
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Albireo Pharma given historical horizon and risk tolerance towards Albireo Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Albireo Pharma, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
In addition, we conduct extensive research on individual companies such as Albireo and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Albireo Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Execute Albireo Pharma Buy or Sell Advice

The Albireo recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Albireo Pharma. Macroaxis does not own or have any residual interests in Albireo Pharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Albireo Pharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Albireo PharmaBuy Albireo Pharma
Not Rated
For the selected time horizon Albireo Pharma has a Risk Adjusted Performance of 0.0881, Jensen Alpha of 1.64, Total Risk Alpha of 0.0521, Sortino Ratio of 0.6297 and Treynor Ratio of (0.72)
Albireo Pharma advice module can be used to check and cross-verify current investment recommendation provided by analysts analyzing the company's potential to grow using all of fundamental, technical, data market data available at the time. To make sure Albireo Pharma is not overpriced, please confirm all Albireo Pharma fundamentals, including its revenue, current ratio, and the relationship between the number of shares shorted and cash and equivalents . Given that Albireo Pharma has a price to earning of (4.16) X, we suggest you to validate Albireo Pharma market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Albireo Pharma Trading Alerts and Improvement Suggestions

Albireo Pharma is not yet fully synchronised with the market data
Albireo Pharma has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 40.58 M. Net Loss for the year was (34.03 M) with profit before overhead, payroll, taxes, and interest of 39.22 M.
Albireo Pharma currently holds about 180.97 M in cash with (107.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.23.
Over 96.0% of the company shares are held by institutions such as insurance companies

Albireo Pharma Returns Distribution Density

The distribution of Albireo Pharma's historical returns is an attempt to chart the uncertainty of Albireo Pharma's future price movements. The chart of the probability distribution of Albireo Pharma daily returns describes the distribution of returns around its average expected value. We use Albireo Pharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Albireo Pharma returns is essential to provide solid investment advice for Albireo Pharma.
Mean Return
1.50
Value At Risk
-3
Potential Upside
5.41
Standard Deviation
11.63
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Albireo Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Albireo Pharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Albireo . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Albireo Pharma Buy or Sell Advice

When is the right time to buy or sell Albireo Pharma? Buying financial instruments such as Albireo Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Albireo Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Construction Thematic Idea Now

Construction
Construction Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Construction theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Construction Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in Albireo Stock

If you are still planning to invest in Albireo Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albireo Pharma's history and understand the potential risks before investing.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios